Argent Biopharma Limited has released a press release.
Investor presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Argent Biopharma
- Mxc completes first artemic order, march qtr record revenue
- Ethics Committee Approval Granted Phase III Clinical Trial
- SwissPharmaCan AG increases initial purchase order
- MGC Pharma first medicinal cannabis company to list on LSE
- MGC Pharma Investor Presentation
Later from Argent Biopharma
- Mgc pharma to acquire medical research company medicanl
- March quarterly activity and cashflow report
- Artemic submitted to health canada
- $1M order for artemic rescue from swiss pharmacan
- Further findings on artemic as anti-inflammatory agent
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma